139 related articles for article (PubMed ID: 27943063)
1. Association of PDCD1 gene markers with susceptibility to thyroid cancer.
Haghshenas MR; Dabbaghmanesh MH; Miri A; Ghaderi A; Erfani N
J Endocrinol Invest; 2017 May; 40(5):481-486. PubMed ID: 27943063
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.
Zhang S; Gao X; Wang Y; Jia J; Zhang Q; Ji Z
Tumour Biol; 2015 Sep; 36(10):8207-11. PubMed ID: 25994572
[TBL] [Abstract][Full Text] [Related]
3. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
4. Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients.
Namavar Jahromi F; Samadi M; Mojtahedi Z; Haghshenas MR; Taghipour M; Erfani N
Immunol Invest; 2017 Jul; 46(5):469-480. PubMed ID: 28535114
[TBL] [Abstract][Full Text] [Related]
5. Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population.
Shamsdin SA; Karimi MH; Hosseini SV; Geramizadeh B; Fattahi MR; Mehrabani D; Moravej A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):693-698. PubMed ID: 29580042
[TBL] [Abstract][Full Text] [Related]
6. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus.
Mahmoudi M; Rezaiemanesh A; Salmaninejad A; Harsini S; Poursani S; Bahrami T; Tahghighi F; Ziaee V; Rezaei N
Autoimmunity; 2015; 48(7):488-93. PubMed ID: 26108738
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer.
Mojtahedi Z; Mohmedi M; Rahimifar S; Erfani N; Hosseini SV; Ghaderi A
Gene; 2012 Oct; 508(2):229-32. PubMed ID: 22892379
[TBL] [Abstract][Full Text] [Related]
8. Possible roles of the xenobiotic transporter P-glycoproteins encoded by the MDR1 3435 C>T gene polymorphism in differentiated thyroid cancers.
Ozdemir S; Uludag A; Silan F; Atik SY; Turgut B; Ozdemir O
Asian Pac J Cancer Prev; 2013; 14(5):3213-7. PubMed ID: 23803106
[TBL] [Abstract][Full Text] [Related]
9. PDCD1 Single Nucleotide Polymorphisms in Iranian Patients With Juvenile Idiopathic Arthritis.
Mahmoudi M; Rezaiemanesh A; Harsini S; Salmaninejad A; Poursani S; Bahrami T; Ziaee V; Rezaei N
Acta Med Iran; 2017 Nov; 55(11):676-682. PubMed ID: 29307156
[TBL] [Abstract][Full Text] [Related]
10. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
11. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
[TBL] [Abstract][Full Text] [Related]
12. Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F; Ebrahimi M; Eslami A; Hafezi H; Eskandari N; Motedayyen H
Int J Immunogenet; 2019 Dec; 46(6):444-450. PubMed ID: 31293069
[TBL] [Abstract][Full Text] [Related]
13. HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series.
Cantara S; Marzocchi C; Castagna MG; Pacini F
J Endocrinol Invest; 2017 May; 40(5):557-560. PubMed ID: 27873212
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of p53 gene mutation with pathological characteristics and prognosis of thyroid carcinoma].
Song Y; Wang L; Huang G; Yuan S; Xiao L
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):298-9, 314. PubMed ID: 12545813
[TBL] [Abstract][Full Text] [Related]
15. PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients.
Fichna M; Zurawek M; Januszkiewicz-Lewandowska D; Fichna P; Nowak J
Int J Immunogenet; 2010 Oct; 37(5):367-72. PubMed ID: 20518841
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
[TBL] [Abstract][Full Text] [Related]
17. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.
Witte J; Lehmann S; Wulfert M; Yang Q; Röher HD
World J Surg; 2007 Jan; 31(1):51-9. PubMed ID: 17171498
[TBL] [Abstract][Full Text] [Related]
19. PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck.
Fathi F; Faghih Z; Khademi B; Kayedi T; Erfani N; Gahderi A
Immunol Invest; 2019 Jan; 48(1):1-10. PubMed ID: 30375891
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.
Fathi F; Zamani B; Piroozmand A; Mozafarpoor S; Seyedhashemi E; ArefNezhad R; Motedayyen H
Mol Biol Rep; 2021 Mar; 48(3):2047-2052. PubMed ID: 33389528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
